1. Ellfolk M, Leinonen MK, Gissler M, Kiuru-Kuhlefelt S, Saastamoinen L, Malm H. Second-generation antipsychotic use during pregnancy and risk of congenital malformations. Eur J Clin Pharmacol. 2021 Nov;77(11):1737–45.
2. Andrade C. Gestational and Neurodevelopmental Outcomes Associated with Antipsychotic Drug Exposure During Pregnancy. J Clin Psychiatry. 2021. https://www.psychiatrist.com/jcp/psychopharmacology/gestational-and-neurodevelopmental-outcomes-associated-with-antipsychotic-drug-exposure-during-pregnancy/
3. Viguera AC, Freeman MP, Góez-Mogollón L, Sosinsky AZ, McElheny SA, Church TR, et al. Reproductive Safety of Second-Generation Antipsychotics: Updated Data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. J Clin Psychiatry. 2021 Aug 3;82(4):35609.
4. Damkier P, Christensen LS, Broe A. Patterns and predictors for prescription of psychotropics and mood-stabilizing antiepileptics during pregnancy in Denmark 2000-2016. Br J Clin Pharmacol. 2018 Nov;84(11):2651–62.
5. Park Y, Huybrechts KF, Cohen JM, Bateman BT, Desai RJ, Patorno E, et al. Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States. PS. 2017 Nov;68(11):1112–9.
6. Anderson KN, Ailes EC, Lind JN, Broussard CS, Bitsko RH, Friedman JM, et al. Atypical antipsychotic use during pregnancy and birth defect risk: National Birth Defects Prevention Study, 1997–2011. Schizophrenia Research. 2020 Jan;215:81–8.
7. Seki R, Hashimoto T, Tanaka M, Sato A, Kimura H, Kimura A, et al. Relapse of psychiatric symptoms after discontinuation of antipsychotics in pregnant women with schizophrenia: a retrospective study. CNPT. 2020 Oct 2;11(0):61–6. https://www.jstage.jst.go.jp/article/cnpt/11/0/11_61/_pdf/-char/ja
8. Faramarzi M, Kheirkhah F, Barat S, Cuijpers P, O’Connor E, Ghadimi R, et al. Prevalence and Factors related of psychiatric symptoms in low risk pregnancy. Caspian J Intern Med. 2020;11(2). https://doi.org/10.22088/cjim.11.2.211
9. Chokhawala K, Stevens L. Antipsychotic Medications. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2022 Jun 6]. http://www.ncbi.nlm.nih.gov/books/NBK519503
10. Hálfdánarson Ó, Cohen JM, Karlstad Ø, Cesta CE, Bjørk MH, Håberg SE, et al. Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study. Evid Based Mental Health. 2021 Nov 22;ebmental-2021-300311.
11. RCP. Antipsychotics in pregnancy | Royal College of Psychiatrists. Royal College of Psychiatrists. 2018. https://www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/antipsychotics-in-pregnancy.
12. Ellfolk M, Leinonen MK, Gissler M, Lahesmaa-Korpinen AM, Saastamoinen L, Nurminen ML, et al. Second-generation antipsychotics and pregnancy complications. Eur J Clin Pharmacol. 2020 Jan;76(1):107–15.
13. Heinonen E, Forsberg L, Nörby U, Wide K, Källén K. Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden. CNS Drugs. 2022 May;36(5):529–39.
14. Park Y, Hernandez-Diaz S, Bateman BT, Cohen JM, Desai RJ, Patorno E, et al. Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. American Journal of Psychiatry. 2018 Jun;175(6):564–74.